Sudan Loganathan
Stock Analyst at Stephens & Co.
(0.6)
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
EXEL Exelixis | Upgrades: Overweight | 29 60 | 45.72 | 31.23% | 5 | Jun 24, 2025 | |
DCTH Delcath Systems | Reiterates: Overweight | 25 25 | 13.87 | 80.25% | 3 | Jun 23, 2025 | |
BPMC Blueprint Medicines | Downgrades: Equal-Weight | 150 135 | 128.25 | 5.26% | 3 | Jun 3, 2025 | |
ELEV Elevation Oncology | Downgrades: Equal-Weight | 5 5 | n/a | n/a | 4 | Mar 24, 2025 | |
IMNM Immunome | Reiterates: Overweight | 30 30 | 8.95 | 235.2% | 2 | Mar 20, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 33 33 | 22.09 | 49.39% | 2 | Feb 27, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 6 8 | 2.86 | 179.72% | 2 | Feb 24, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 50 50 | 21.8 | 129.36% | 2 | Feb 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Equal-Weight | 15 15 | 7.36 | 103.8% | 2 | Jan 22, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 31 31 | 11.97 | 158.98% | 3 | Jan 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 60 60 | 47.16 | 27.23% | 2 | Jan 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 5 5 | 1.69 | 195.86% | 2 | Nov 19, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Equal-Weight | 4 | 1.57 | 154.78% | 1 | Nov 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 55 | 7.72 | 612.44% | 1 | Nov 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 13 | 1.28 | 915.62% | 1 | Nov 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 100 100 | 8.3 | 1104.82% | 2 | May 24, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 20 | 2.06 | 870.87% | 1 | May 14, 2024 |